דילטיאזם טבע 60 מג ישראל - עברית - Ministry of Health

דילטיאזם טבע 60 מג

teva pharmaceutical industries ltd, israel - diltiazem hydrochloride - טבליה - diltiazem hydrochloride 60 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.

רמיפריל פלוס טבע    2.5 מג 12.5 מג ישראל - עברית - Ministry of Health

רמיפריל פלוס טבע 2.5 מג 12.5 מג

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

רמיפריל פלוס טבע    2.5 מג12.5 מג ישראל - עברית - Ministry of Health

רמיפריל פלוס טבע 2.5 מג12.5 מג

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

רמיפריל פלוס טבע   5 מג25 מג ישראל - עברית - Ministry of Health

רמיפריל פלוס טבע 5 מג25 מג

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

רמיפריל פלוס טבע   5 מג25 מג ישראל - עברית - Ministry of Health

רמיפריל פלוס טבע 5 מג25 מג

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ציפרופלוקסצין טבע 500 מג ישראל - עברית - Ministry of Health

ציפרופלוקסצין טבע 500 מג

teva israel ltd - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 500 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

ציפרופלוקסצין טבע 250 מג ישראל - עברית - Ministry of Health

ציפרופלוקסצין טבע 250 מג

teva pharmaceutical industries ltd, israel - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 250 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

ציפרופלוקסצין טבע 750 מג ישראל - עברית - Ministry of Health

ציפרופלוקסצין טבע 750 מג

teva pharmaceutical industries ltd, israel - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 750 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

פרבסטאטין טבע 40 מג ישראל - עברית - Ministry of Health

פרבסטאטין טבע 40 מג

teva israel ltd - pravastatin sodium - טבליה - pravastatin sodium 40 mg - hmg coa reductase inhibitors - pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . pravastatin should be used in addition to a diet restricted in saturated fat and cholesterol when the response to diet and other nonpharmacological measures alone has been inadequate. *primary prevention of coronary events: in hypercholesterolemic patients whthout clinically evident coronary heart disease pravastatin is indicated to: - reduce the risk of myocardial infarcton. - reduce the risk for revascularization. - reduce the risk of deaths due to cardiovascular causes with no increase in deaths from non-cardiovascular causes. *secondary prevention of cardiovascular events: atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior mi pravastatin is indicated to: - slow the progression of coronary atherosclerosis. - reduce the risk of acute coronary events. myocardial infa

אטאזנביר טבע  150 מג ישראל - עברית - Ministry of Health

אטאזנביר טבע 150 מג

teva israel ltd - atazanavir as sulfate - קפסולות - atazanavir as sulfate 150 mg - atazanavir